The Vanguard International High Dividend Yield ETF (VYMI) is rated Buy due to its strong sector positioning in financials, energy, and healthcare, which supports dividend growth and capital appreciation. It has outperformed peers with a 5-year average annual return of 14.13% and offers a 3.61% dividend yield with attractive valuation metrics. Key holdings like HSBC, Royal Bank of Canada, Roche, Novartis, and Shell provide stability and sustainable dividends. Risks include high exposure to financials and currency fluctuations, but these are mitigated by sector tailwinds and value-oriented investments, making VYMI a compelling choice for diversified international dividend investors.
As of Sep 21, 2026 16:21 WIB, the Vanguard International High Dividend Yield ETF (VYMI) trades at USD 103.35, up 0.21% on Pluang. Key holdings like HSBC and Shell also show positive moves, with HSBC up 1.17% at USD 103.02 and Shell rising 0.36% to USD 94.88. VYMI's market cap stands at $22.80 billion, highlighting its significant presence in the international dividend ETF space.
The Vanguard International High Dividend Yield ETF (VYMI) maintained positive absolute returns even as US economic growth rebounded strongly and the Federal Reserve confirmed a higher-for-longer interest rate stance. This environment compressed valua...
Schwab's SCHY ETF, designed as the international counterpart to its popular SCHD U.S. dividend fund, faces strong competition from Vanguard's VYMI, Fidelity's FIDI, and BlackRock's IDV. Among these, Vanguard's VYMI stands out with a lower fee, broade...
